Evaluation of Pancreatic VMAT2 Binding with Active and Inactive Enantiomers of [18F]FP-DTBZ in Healthy Subjects and Patients with Type 1 Diabetes
Purpose Previous studies demonstrated the utility of [ 18 F]fluoropropyl-(+)-dihydrotetrabenazine ([ 18 F]FP-(+)-DTBZ) as a positron emission tomography (PET) radiotracer for the vesicular monoamine transporter type 2 (VMAT2) to quantify beta cell mass in healthy control (HC) and type 1 diabetes mel...
Gespeichert in:
Veröffentlicht in: | Molecular imaging and biology 2018-10, Vol.20 (5), p.835-845 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Purpose
Previous studies demonstrated the utility of [
18
F]fluoropropyl-(+)-dihydrotetrabenazine ([
18
F]FP-(+)-DTBZ) as a positron emission tomography (PET) radiotracer for the vesicular monoamine transporter type 2 (VMAT2) to quantify beta cell mass in healthy control (HC) and type 1 diabetes mellitus (T1DM) groups. Quantification of specific binding requires measurement of non-displaceable uptake. Our goal was to identify a reference tissue (renal cortex or spleen) to quantify pancreatic non-specific binding of [
18
F]FP-(+)-DTBZ with the inactive enantiomer, [
18
F]FP-(−)-DTBZ. This was the first human study of [
18
F]FP-(−)-DTBZ.
Procedures
Six HCs and four T1DM patients were scanned on separate days after injection of [
18
F]FP-(+)-DTBZ or [
18
F]FP-(−)-DTBZ. Distribution volumes (
V
T
) and standardized uptake values (SUVs) were compared between groups. Three methods for calculation of non-displaceable uptake (
V
ND
) or reference SUV were applied: (1) use of [
18
F]FP-(+)-DTBZ reference
V
T
as
V
ND
, assuming
V
ND
is uniform across organs; (2) use of [
18
F]FP-(−)-DTBZ pancreatic
V
T
as
V
ND
, assuming that
V
ND
is uniform between enantiomers in the pancreas; and (3) use of a scaled [
18
F]FP-(+)-DTBZ reference
V
T
as
V
ND
, assuming that a ratio of non-displaceable uptake between organs is uniform between enantiomers. Group differences in
V
T
(or SUV), binding potential (
BP
ND
), or SUV ratio (SUVR) were estimated using these three methods.
Results
[
18
F]FP-(−)-DTBZ
V
T
values were different among organs, and
V
T
(+) and
V
T
(−) were also different in the renal cortex and spleen. Method 3 with the spleen to estimate
V
ND
(or reference SUV) gave the highest non-displaceable uptake and the largest HC
vs.
T1DM group differences. Significant group differences were also observed in
V
T
(or SUV) with method 1 using spleen. SUV was affected by differences in the input function between groups and between enantiomers.
Conclusions
Non-displaceable uptake was different among organs and between enantiomers. Use of scaled spleen
V
T
values for
V
ND
is a suitable method for quantification of VMAT2 in the pancreas. |
---|---|
ISSN: | 1536-1632 1860-2002 |
DOI: | 10.1007/s11307-018-1170-6 |